1PAUWELS R A, BUIST A S, CALVERLEY P M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstruction pulmonary disease. NHLBI/WHO Global initiative for Chronic Obstructive Lung Disease(GOLD) Workshop summary[ J]. Am J Rest Crit Care Med, 2001 , 163 ( 5 ) : 1256 - 1276.
8STRUCKMANN N, SCHWERING S, WIEGAND S, et al. Role of muscarinic receptor subtypes in the constriction of peripheral airway: studies on receptor-deficient mice [ J ]. Mol Pharmacol, 2003,64 : 1444 - 1451.
9BRUSASCO V, HODDER R, MIRAVITLLES M, et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD [ J ]. Thorax,2003,58:399 - 404.
6Sian E, Bsc T, Peter R, et al. Incremental and walking exercise in patients with COPD [ J ]. Chest, 2004,126:766 - 773.
7Gigliotti F, Coli C, Bianchi R, et al. Ann exercise and hyperinflation in patients with COPD : effect of arm training [ J ]. Chest, 2005,128 : 1225 - 1232.
8Mador M, Deniz O, Aggarwal A, et al. Effect of respiratory muscle endurance training in patients with COPD undergoing pulmonary rehabilitation[ J]. Chest ,2005,128 : 1216 - 1224.
9Leupoldt A, Taube K, schubert S, et al. Helpful depopulate dyspnea of exercising distraction attention in patients with COPD [ J ]. Chest,2007,132 : 1506 - 1512.
10Nair S, Thomas F, Dphil P, et al. A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD [ J ]. Chest,2005,128:48 - 54.
